These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 19507862)

  • 21. Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumors.
    Koblish HK; Hansbury MJ; Bowman KJ; Yang G; Neilan CL; Haley PJ; Burn TC; Waeltz P; Sparks RB; Yue EW; Combs AP; Scherle PA; Vaddi K; Fridman JS
    Mol Cancer Ther; 2010 Feb; 9(2):489-98. PubMed ID: 20124451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase.
    Banerjee T; Duhadaway JB; Gaspari P; Sutanto-Ward E; Munn DH; Mellor AL; Malachowski WP; Prendergast GC; Muller AJ
    Oncogene; 2008 May; 27(20):2851-7. PubMed ID: 18026137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2.
    Austin CJ; Mailu BM; Maghzal GJ; Sanchez-Perez A; Rahlfs S; Zocher K; Yuasa HJ; Arthur JW; Becker K; Stocker R; Hunt NH; Ball HJ
    Amino Acids; 2010 Jul; 39(2):565-78. PubMed ID: 20140689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
    Bakmiwewa SM; Fatokun AA; Tran A; Payne RJ; Hunt NH; Ball HJ
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7641-6. PubMed ID: 23122865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice.
    Ball HJ; Sanchez-Perez A; Weiser S; Austin CJ; Astelbauer F; Miu J; McQuillan JA; Stocker R; Jermiin LS; Hunt NH
    Gene; 2007 Jul; 396(1):203-13. PubMed ID: 17499941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiosemicarbazide, a fragment with promising indolamine-2,3-dioxygenase (IDO) inhibition properties.
    Serra S; Moineaux L; Vancraeynest C; Masereel B; Wouters J; Pochet L; Frédérick R
    Eur J Med Chem; 2014 Jul; 82():96-105. PubMed ID: 24878638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diazotization of kynurenine by acidified nitrite secreted from indoleamine 2,3-dioxygenase-expressing myeloid dendritic cells.
    Hara T; Yamakura F; Takikawa O; Hiramatsu R; Kawabe T; Isobe K; Nagase F
    J Immunol Methods; 2008 Mar; 332(1-2):162-9. PubMed ID: 18158157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells.
    Lee SY; Choi HK; Lee KJ; Jung JY; Hur GY; Jung KH; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
    J Immunother; 2009 Jan; 32(1):22-8. PubMed ID: 19307990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation.
    Munn DH
    Curr Opin Immunol; 2006 Apr; 18(2):220-5. PubMed ID: 16460921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse model for allogeneic immune reaction against fetus recapitulates human pre-eclampsia.
    Nishizawa H; Hasegawa K; Suzuki M; Achiwa Y; Kato T; Saito K; Kurahashi H; Udagawa Y
    J Obstet Gynaecol Res; 2008 Feb; 34(1):1-6. PubMed ID: 18226121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oren-gedoku-to and its constituents with therapeutic potential in Alzheimer's disease inhibit indoleamine 2, 3-dioxygenase activity in vitro.
    Yu CJ; Zheng MF; Kuang CX; Huang WD; Yang Q
    J Alzheimers Dis; 2010; 22(1):257-66. PubMed ID: 20847417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indoleamine 2,3-dioxygenase inhibitors: a patent review (2008 - 2012).
    Dolušić E; Frédérick R
    Expert Opin Ther Pat; 2013 Oct; 23(10):1367-81. PubMed ID: 23992582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.
    Dolušić E; Larrieu P; Blanc S; Sapunaric F; Pouyez J; Moineaux L; Colette D; Stroobant V; Pilotte L; Colau D; Ferain T; Fraser G; Galleni M; Frère JM; Masereel B; Van den Eynde B; Wouters J; Frédérick R
    Eur J Med Chem; 2011 Jul; 46(7):3058-65. PubMed ID: 21419531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock.
    Jung ID; Lee MG; Chang JH; Lee JS; Jeong YI; Lee CM; Park WS; Han J; Seo SK; Lee SY; Park YM
    J Immunol; 2009 Mar; 182(5):3146-54. PubMed ID: 19234212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Research progress of indoleamine 2,3-dioxygenase inhibitors.
    Jiang T; Sun Y; Yin Z; Feng S; Sun L; Li Z
    Future Med Chem; 2015; 7(2):185-201. PubMed ID: 25686005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mouse and human indoleamine 2,3-dioxygenase display some distinct biochemical and structural properties.
    Austin CJ; Astelbauer F; Kosim-Satyaputra P; Ball HJ; Willows RD; Jamie JF; Hunt NH
    Amino Acids; 2009 Jan; 36(1):99-106. PubMed ID: 18274832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy.
    Lin SY; Yeh TK; Song JS; Hung MS; Cheng MF; Liao FY; Li AS; Cheng SY; Lin LM; Chiu CH; Wu MH; Lin YJ; Hsiao W; Sun M; Wang YH; Huang CH; Tang YC; Chang HH; Huang ZT; Chao YS; Shih C; Pan SL; Wu SY; Kuo CC; Ueng SH
    Bioorg Chem; 2018 Apr; 77():600-607. PubMed ID: 29494816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Curcumin inhibiting the expression of indoleamine 2,3-dioxygenase induced by IFN-gamma in cancer cells].
    Zhang KS; Li GC; He YW; Yi YM; Liao SL; Wang Z; Du J
    Zhong Yao Cai; 2008 Aug; 31(8):1207-11. PubMed ID: 19112904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerated rejection of the second transplants of immunogenic tumor in mice under inhibition of indoleamine 2,3-dioxygenase activity by ethyl pyruvate.
    Vasilyeva ED; Kaledin V; Nikolin VP; Popova NA; Kirilyuk IA; Grigor'ev IA
    Exp Oncol; 2012; 34(1):66-8. PubMed ID: 22453153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.
    Dolušić E; Larrieu P; Blanc S; Sapunaric F; Norberg B; Moineaux L; Colette D; Stroobant V; Pilotte L; Colau D; Ferain T; Fraser G; Galleni M; Frère JM; Masereel B; Van den Eynde B; Wouters J; Frédérick R
    Bioorg Med Chem; 2011 Feb; 19(4):1550-61. PubMed ID: 21269836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.